Andrea Muth

Plattform Manager @D11Z

📍 Germany🔄 Updated September 2026💼 6 investments📅 4 years investing🗓 Last invested Jan 2024
VC🌍 Germany
6
Total investments
3
Early stage
1
Mid stage
2
Late stage
4y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2024
Weather data for mobility
Investor
Aug 2023
At actble, we revolutionize ballet with custom-fit and modular pointe shoes. By using 3D printing, we create pointe shoes matching each dancers unique feet for increased support, movement range and durability as well as to reduce pain. We are thriving for a healthier dance community, innovative solutions and sustainable future! Follow our journey and contact us to order shoes for your dance company or school.
Investor
Apr 2023
our mission is to optimise the highly complex and iterative design process by providing a digital designer’s muse - an algorithm that can identify and extract the brand’s dna to cre[ai]te future designs.
early stageDesign Services
Investor
Oct 2022
We are a tech company based in Münster, Germany, pioneering the chemical recycling of cotton-polyester textiles. Founded in 2019, we have developed a breakthrough technology that efficiently separates and recovers cellulose and PET monomers. These high-quality materials serve as the basis for virgin-quality fibers, enabling the transition toward a fully circular textile industry.
Investor
Sep 2022
At PL BioScience, we are experts in Human Platelet Lysate. Our mission is to support advances in cellular research and therapy with our revolutionary technology: the ELAREM™ HPL platform. Its xeno-free origin, combined with its naturally rich growth factor content not only supports cell growth and expansion, but also enables various applications. And with Research- and GMP-grade products available, ELAREM™ covers all steps of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from blood bank, to bench, to bedside. Our story goes back to 2015, with the mission to deliver xeno-free cell culture supplements. Today, we continue to change the possibilities of cell expansion; researchers switch from Fetal Bovine Serum to our animal suffering-free products. Our signature innovation continues to guide us, as we work to support all stages of research, with premium quality HPL. Join us today in Innovating Cell Culture!
late stageBiotechnology
Investor
Sep 2022
Die Preventicus GmbH ist ein Digital-Health-Unternehmen, das grundlegend neue digitale Produkte und Dienstleistungen zur Erkennung von Vorhofflimmern entwickelt und vermarktet. Preventicus ist der Erfinder von Preventicus Heartbeats, einer intelligenten Screening-Lösung zur Erkennung von Vorhofflimmern zur Schlaganfallprävention, die auf Technologien basiert, die in einem Standard-Smartphone oder einer Smartwatch vorhanden sind.
Experience · 8 entries
All (8)
Investments (6)
2024
Investor
Jan 2024
Weather data for mobility
2023
Investor
Aug 2023
At actble, we revolutionize ballet with custom-fit and modular pointe shoes. By using 3D printing, we create pointe shoes matching each dancers unique feet for increased support, movement range and durability as well as to reduce pain. We are thriving for a healthier dance community, innovative solutions and sustainable future! Follow our journey and contact us to order shoes for your dance company or school.
Investor
Apr 2023
our mission is to optimise the highly complex and iterative design process by providing a digital designer’s muse - an algorithm that can identify and extract the brand’s dna to cre[ai]te future designs.
early stageDesign Services
2022
Investor
Oct 2022
We are a tech company based in Münster, Germany, pioneering the chemical recycling of cotton-polyester textiles. Founded in 2019, we have developed a breakthrough technology that efficiently separates and recovers cellulose and PET monomers. These high-quality materials serve as the basis for virgin-quality fibers, enabling the transition toward a fully circular textile industry.
Investor
Sep 2022
At PL BioScience, we are experts in Human Platelet Lysate. Our mission is to support advances in cellular research and therapy with our revolutionary technology: the ELAREM™ HPL platform. Its xeno-free origin, combined with its naturally rich growth factor content not only supports cell growth and expansion, but also enables various applications. And with Research- and GMP-grade products available, ELAREM™ covers all steps of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from blood bank, to bench, to bedside. Our story goes back to 2015, with the mission to deliver xeno-free cell culture supplements. Today, we continue to change the possibilities of cell expansion; researchers switch from Fetal Bovine Serum to our animal suffering-free products. Our signature innovation continues to guide us, as we work to support all stages of research, with premium quality HPL. Join us today in Innovating Cell Culture!
late stageBiotechnology
Show all 8 entries ↓
Investment activity
2022–2024 · 6 investments
202232023220241
Recent (last 2 years)Earlier